Resonant (RESN) Financials

$4.48

$0.00 (0.00%)

As on 06-Apr-2022 09:30EDT

Market cap

$301 Mln

Revenue (TTM)

$2 Mln

P/E Ratio

--

P/B Ratio

19.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Operating Revenue	2.18	3.16	0.74	0.52	0.65	0.30
Cost of Revenue	--	--	--	--	18.96	14.49
Gross Profit	2.18	0.00	0.74	0.52	0.65	0.30
Operating Expenses	38.13	31.63	30.89	25.82	19.69	15.59
Operating Profit (EBIT)	-35.95	-28.47	-30.16	-25.29	-19.04	-15.29
Other Income	-0.02	0.05	0.23	0.48	-2.63	0.02
Profit before Tax	-35.97	-28.41	-29.93	-24.82	-21.67	-15.27
Provision for Tax	0.00	0.00	0.00	0.00	-0.01	-0.02
Profit after Tax (Net Income)	-35.97	-28.41	-29.93	-24.82	-21.65	-15.25
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-35.97	-28.41	-29.93	-24.82	-21.65	-15.25

Liabilities ($ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Shareholder's Funds	15.26	25.05	9.76	22.90	20.65	10.13
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	6.10	1.83	2.06	0.08	0.01	0.06
Current Liabilities	7.00	5.85	6.33	3.27	3.10	3.00
Total Liabilities	28.36	32.73	18.15	26.24	23.76	13.20

Assets ($ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Non-Current Assets	6.42	7.04	7.01	4.46	3.55	3.15
Current Assets	21.95	25.69	11.14	21.79	20.21	10.05
Total Assets	28.36	32.73	18.15	26.24	23.76	13.20
Total Debt*	1.78	2.49	2.67	--	--	--
Net Current Assets	14.94	19.84	4.81	18.52	17.11	--

Cashflow ($ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Cash From Operating Activities	-20.10	-21.64	-20.71	-18.13	-14.47	-10.66
Cash Flow from Investing Activities	-1.96	-1.59	15.63	-18.20	3.61	-2.83
Cash from Financing Activities	18.25	37.46	11.31	21.31	25.30	16.08
Net Cash Inflow / Outflow	-3.81	14.23	6.23	-15.02	14.44	2.58

Financials Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Adjusted EPS ($)	--	-0.58	-0.56	-1.03	-0.99	-1.44
Cash EPS ($)	--	-0.55	-0.53	-0.98	-0.96	-1.40
Adjusted Book Value ($)	--	0.25	0.49	0.34	0.92	1.38
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.32	-0.42	-0.71	-0.73	-0.96
Free Cash Flow per Share ($)	--	-0.36	-0.46	-0.76	-0.79	-1.04

Profitability Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
ROCE (%)	--	-161.37	-142.17	-169.44	-113.98	-140.69
ROE (%)	--	-178.47	-163.26	-183.30	-113.98	-140.69
ROA (%)	--	-117.76	-111.70	-134.84	-99.26	-117.17
EBIT Margin (%)	--	-1,650.78	-898.77	-4,037.28	-4,735.69	-3,318.07
Net Margin (%)	--	-1,662.97	-884.07	-3,094.93	-2,476.65	1,094.69
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Revenue Growth (%)	--	-0.31	3.30	0.40	-0.20	1.16
EBIT Growth (%)	--	-26.59	4.29	-19.58	-14.53	-41.90
Net Profit Growth (%)	--	-26.59	5.06	-20.60	-14.61	-42.01
EPS Growth (%)	--	-0.04	0.46	-0.04	0.31	0.05
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Price / Earnings	--	-2.95	-4.76	-2.34	-1.34	-5.17
Price / Book Value	--	6.95	5.39	7.19	1.45	5.43
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	-2.52	-4.20	-2.21	-0.50	-4.42
Close Price ($)	--	1.71	2.65	2.42	1.33	7.47
High Price ($)	--	8.33	3.29	4.00	7.99	8.55
Low Price ($)	--	1.69	0.95	1.25	0.92	3.82
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Debt to Equity	--	0.12	0.10	0.27	--	--
Short term debt to equity ratio	--	0.04	0.03	0.06	--	--
Current Ratio	--	3.13	4.39	1.76	6.67	6.52
Quick Ratio	--	--	--	--	--	6.52
Interest Coverage	--	--	--	--	--	--

Operating Efficiency Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Debtors to sales (%)	--	2.20	6.58	10.61	31.49	7.66
Asset Turnover	--	0.07	0.12	0.03	0.02	0.04
Receivable days	--	21.47	16.53	60.38	74.93	29.65
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	33.03
Cash Conversion Cycle	--	--	--	--	--	-3.38